MJP Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
MJP Associates's AMGN Position: Q2 2026 in Review
MJP Associates reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $108K and leaving 2,286 shares worth $828K. The position accounts for 0.09% of the portfolio, ranked #85.
MJP Associates first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.46M in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- MJP Associates held 2,286 shares of Amgen worth $828K as of Q2 2026.
- MJP Associates sold 315 Amgen shares in Q2 2026, an estimated $108K.
- Amgen made up 0.09% of MJP Associates's portfolio in Q2 2026, its #85 holding.
- MJP Associates first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
- MJP Associates's Amgen position peaked at $1.46M in Q4 2025.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on MJP Associates's 13F filing for Q2 2026, filed 11 Aug 2026.